Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Greenwich Lifesciences Inc GLSI

Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of GP2, immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the human epidermal growth factor receptor 2 (HER2)/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers. GP2 is delivered in combination with granulocyte-macrophage colony-stimulating factor to induce GP2 peptide-specific immunity. GP2 treatment is administered via an intradermal injection by mixing GP2 peptide and GM-CSF at the time of administration. Its cancer immunotherapy seeks to stimulate an individual's immune system to selectively attack cancer cells while not affecting normal cells or to deliver immune system components to inhibit the spread of cancer. It has commenced a Phase III clinical trial, Flamingo-01 an immunotherapy to prevent breast cancer recurrences.


NDAQ:GLSI - Post by User

Bullboard Posts
Post by StockMountieon Mar 12, 2015 12:45pm
163 Views
Post# 23514203

Launches First-to-Market Fan Engagement Experience

Launches First-to-Market Fan Engagement Experience bBooth, Inc. (BBTH) Launches First-to-Market Fan Engagement Experience Through Its Video-Sharing App Songstagram (Soon-to-Be-Named 'kord') Unprecedented, Targeted Fan Engagement and Monetization Opportunities for Artists; First Featured Artist is 2015 Grammy-Nominated Singer Angie Fisher; More Coming HOLLYWOOD, CALIFORNIA--(Marketwired - Mar 12, 2015) - bBooth, Inc. (BBTH) announces today it has introduced new features in its app Songstagram, soon-to-be rebranded as 'kord', that provide all music artists with new and additional monetization opportunities through its unique fan engagement features now available. Built on a robust social media platform with state-of-the-art, proprietary messaging and video-sharing technology, Songstagram/kord provides a unique experience to both consumers and artists alike. Instead of just listening, fans can interact with the music of their favorite artists. Users can record and share up to four and a half minutes of their own versions of their favorite songs or add their favorite artists' music to videos they already have on their iOS and Android mobile devices, and/or Mac and Windows desktop computers. For artists and other content creators, fan engagement and monetization opportunities are unprecedented. With Songstagram/kord, artists no longer have to pay monthly storage fees just so their fans can listen to their music. With Songstagram/kord, artists can upload all their content with no monthly fees. In addition, all artists get their own built-into-the-app store where they can actually sell their content, including merchandise directly to their fan base. Now for the first time, artists can communicate directly with the fans that are consuming their music. The app allows artists to deliver unique targeted messages directly to their fans, offering local performance schedules, merchandise opportunities, and other fan engagement. The first artist to be launched under the newly enhanced app is 2015 Grammy-nominated singer Angie Fisher, whose song "I.R.S." was nominated recently for 'Best Traditional R&B Performance'. Angie let the Songstagram cameras 'come along for the ride', capturing her entire Grammy experience. To get the full video (dropping April 1st) and to listen and interact with her songs, download Songstagram. "It's no secret that the music industry is facing challenges," states Rory J. Cutaia, CEO of bBooth. "Artists no longer earn what they deserve for the art that they create and everyone else enjoys. We're changing that right now. Direct fan engagement is how artists can recover the revenue they lost when digital downloads disrupted the compact disc business. Our platform is truly win-win for artists and consumers." The app is now available on The App Store and Google Play. About bBooth At the forefront of the new, 'experiential, location-based entertainment' movement, bBooth (BBTH)(CUSIP number:07331L 108), The Talent Discovery Company, is deploying kiosk-sized, family-friendly, professional-quality, TV recording studios in local shopping centers across the country. The audition booths are seamlessly integrated into a social media, messaging, gaming, music streaming, video sharing mobile app, creating a new, robust talent discovery platform where both fans and established artists alike have a new way to engage, promote and sell music and other video content. For more information on bBooth, visit www.bBooth.com
Bullboard Posts